X4 Pharmaceuticals Inc.
XFOR | NASDAQ
$3.42
-$0.08 (-2.15%)
Sep 22, 2026, 12:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.14 | -3.94 | -1.47 | -0.65 | -0.57 | -2.08 |
PEG Ratio | 0.03 | 0.06 | 0.02 | 0.01 | -0.02 | 0.06 |
PS Ratio | 4.82 | 57.69 | n/a | n/a | n/a | 43.03 |
PB Ratio | 0.91 | 6.66 | 2.92 | 0.85 | 0.92 | 1.77 |
P/FCF Ratio | -1.91 | -1.07 | -1.54 | -0.82 | -0.82 | -2.15 |
P/OCF Ratio | -1.98 | -1.13 | -1.55 | -0.82 | -0.83 | -2.19 |
OCF/S Ratio | -243.84 | -5.12K | n/a | n/a | n/a | -1.96K |
Debt / Equity Ratio | 0.41 | 3.53 | 1.14 | 0.52 | 0.62 | 0.53 |
Quick Ratio | 9.98 | 3.33 | 5.34 | 5.76 | 6.27 | 6.97 |
Current Ratio | 10.16 | 3.41 | 5.34 | 5.76 | 6.27 | 6.97 |
Asset Turnover | 0.12 | 0.02 | n/a | n/a | n/a | 0.02 |
Interest Coverage | -9.79 | -4.15 | -18.61 | -21.93 | -20.69 | -22.27 |
Return on Equity | -42.51% | -169.08% | -197.98% | -126.76% | -137.70% | -85.35% |
Return on Assets | -27.27% | -25.57% | -68.70% | -60.33% | -75.69% | -50.57% |
Return on Invested Capital | -32.70% | -31.70% | -85.68% | -64.50% | -71.75% | -53.60% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 82.18% | 68.83% | n/a | n/a | n/a | 59% |
Net Profit Margin | -225.55% | -1.46K% | n/a | n/a | n/a | -2.07K% |
Pretax Profit Margin | -225.44% | -1.45K% | n/a | n/a | n/a | -2.07K% |
Operating Profit Margin | -247.44% | -1.42K% | n/a | n/a | n/a | -2K% |
FCF Margin | -252.38% | -5.41K% | n/a | n/a | n/a | -2.01K% |
EBITDA Margin | -196.52% | -1.08K% | n/a | n/a | n/a | -1.95K% |
Add to Watchlist
Select watchlists to add or remove XFOR